590 filings
Page 5 of 30
4/A
074knoh5hkj1v21lwb7k
21 Mar 22
9 METERS BIOPHARMA / Michael T. Constantino ownership change
4:17pm
4
wex o2tpjb61lp
7 Mar 22
9 METERS BIOPHARMA / Mark A Sirgo ownership change
8:01am
4
det5jl
4 Mar 22
9 METERS BIOPHARMA / John Temperato ownership change
8:00am
8-K
2y6h0ms5viwkfbyjdkt
28 Feb 22
9 Meters Biopharma Provides Clinical Update on Late-Stage Pipeline Products Vurolenatide for Short Bowel Syndrome and Larazotide for Celiac Disease
4:22pm
4
ges5p2ttltl597793v
23 Feb 22
9 METERS BIOPHARMA / John Temperato ownership change
4:15pm
8-K
k4wuol1
11 Feb 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
SC 13G/A
fq51yjb05zfb
10 Feb 22
9 METERS BIOPHARMA / ADAGE CAPITAL PARTNERS GP, L.L.C. ownership change
10:35am
SC 13G
nsdejlr b30cpc01hr
4 Feb 22
9 METERS BIOPHARMA / BlackRock ownership change
4:12pm
8-K
85kc1cjhym3fegq
24 Jan 22
9 Meters Biopharma Announces Allowance of Patent for NM-102 in Combination with Immune Checkpoint Inhibitors
8:06am
4
56ico4
18 Jan 22
9 METERS BIOPHARMA / Bethany Sensenig ownership change
7:24pm
3
ygllc
18 Jan 22
9 METERS BIOPHARMA / Bethany Sensenig ownership change
8:06am
8-K
erw xaglbz441p5hv
18 Jan 22
9 Meters Biopharma Appoints Bethany Sensenig as Chief Financial Officer
8:05am
8-K
jhi7moqvc
3 Jan 22
Other Events
7:38am
4
9ir7u3
3 Dec 21
9 METERS BIOPHARMA / Mark A Sirgo ownership change
7:34am
4
7so aex5f
22 Nov 21
9 METERS BIOPHARMA / Mark A Sirgo ownership change
7:30am
4
l6rjll5nzpi231ia 1xv
19 Nov 21
9 METERS BIOPHARMA / John Temperato ownership change
7:31am
8-K
nijqcvz662lpjde8 7v9
15 Nov 21
9 Meters Biopharma Provides Business Update and Reports Financial Results for the Third Quarter 2021
7:34am
8-K
vu65a7yd
10 Nov 21
9 Meters Biopharma, Inc. Announces Immuno-Oncology Collaboration with Gustave Roussy for NM-102, a Gut Microbiome Modulator
7:33am
8-K
ja8rs3
26 Oct 21
2021 Annual Scientific Meeting
7:33am